Anebulo Pharmaceuticals, Inc.
ANEB
Revenue
0.00
0.000.00%
-Assets
9.42M
▼-1.28M▼-11.95%
3 Months ChangeLiabilities
1.49M
▲521.83k▲54.14%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-12
Form 10-Q
ID: 0001493152-26-006446
2026-02-12
Form 8-K
ID: 0001493152-26-006428
2026-02-06
Form 8-K
ID: 0001493152-26-005463
2026-01-29
Form 8-K
ID: 0001493152-26-004154
2026-01-27
Form 8-K
ID: 0001493152-26-003718
2025-12-22
Form 8-K
ID: 0001493152-25-028676
2025-11-13
Form 10-Q
ID: 0001493152-25-022350
2025-11-13
Form 8-K
ID: 0001493152-25-022310
2025-09-29
Form 8-K
ID: 0001493152-25-016001
2025-09-12
Form 8-K
ID: 0001493152-25-013133